Developing national medical technology to serve the public health

Beijing Richen-force Science & Technology Co., Ltd. was established in July 2002. The founder regards "developing national medical technology and serving human health" as its business purpose, and is committed to the research and development, manufacturing, sales and service of high-tech medical products. The company's headquarters is registered in Beijing Zhongguancun Science and Technology Park, with research and development and production bases in Beijing, Guangzhou and Taizhou. It is a high-tech enterprise.

In the 1990s, Richen began to develop the carbon 13 urea breath detection system, and first landed the system in China. It has been committed to the prevention and treatment of Helicobacter pylori prevention and prevention of early gastric cancer. Today, it has been used to provide Chinese people with this product. The service of more than 10 million people has made great contributions to the prevention and treatment of Helicobacter pylori in China. Not only that, Richen 13C urea breath detection system is also going global, serving more than 70 countries and regions around the world to serve the people of the world. Richen is the largest supplier of 13C breath test in the world.
Based on the Department of Gastroenterology, Richen has also developed and represented more quality diagnostic products for the Department of Gastroenterology. For example, PGI/PGII from Korean MiroCam capsule endoscopy, time-resolved fluorescence immunoassay, Hp stool antigen card and heat probe.
Richen Force Holdings is headquartered in Beijing, its wholly-owned subsidiaries: Guangzhou Richen-lab, Guangzhou Richen-Frinse, Jiangsu Richen-Bases, Richen Hong Kong, Richen Europe, Richen Brazil and Richen America.